Divis Laboratories Ltd reported INR17.59B in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Alaunos Therapeutics USD 732K 332K Jun/2026
Aurobindo Pharma INR 58.92B 3.25B Sep/2026
Avita Medical AUD 6.42M 2.54M Jun/2026
Dianthus Therapeutics USD 5.5M 892K Sep/2026
Divis Laboratories Ltd INR 17.59B 5.48B Sep/2026
Ionis Pharmaceuticals USD 27.11M 20.59M Sep/2026
IQVIA Holdings USD 3.68B 68M Sep/2026
Lupin INR 45.58B 3.85B Sep/2026
Moderna USD 259M 92M Sep/2026
Organon & Co USD 982M 69M Sep/2026
Revvity USD 163.27M 2.47M Sep/2026
Tectonic Therapeutic USD 1.68M 877K Jun/2026
Tilray USD 114.5M 3.69M Sep/2025
Viatris USD 1.01B 228.9M Sep/2026
Xeris Pharmaceuticals USD 8.04M 1.3M Sep/2026